The South & Central America brain health supplements market is expected to grow from US$ 655.64 million in 2022 to US$ 1,206.94 million by 2028. It is estimated to grow at a CAGR of 10.7% from 2022 to 2028.
Further, high investments by governments in these countries in life science and health research favor the upgrading of facilities with the latest technologies. This is also driving the brain health supplements market players toward developing regions.
Based on product, the South & Central America brain health supplements market is segmented into natural molecules, herbal extract, and vitamins and minerals. The natural molecules segment registered the largest South & Central America brain health supplements market share in 2022. The natural molecules is further subsegmented into acetyl-L-carnitine, docosahexaenoic Acid (DHA), alpha GPC, citicoline, huperzine-A, and others. The herbal extract is further subsegmented into bacopa monnieri, ginkgo biloba, ginseng, curcumin, lion's mane, and others. The vitamins and minerals is further subsegmented into vitamins C and E, vitamin B complex and others.
Based on application, the South & Central America brain health supplements market is segmented into memory enhancement, attention and focus, depression and mood, sleep and recovery, anti-aging and longevity, and others. The memory enhancement segment held the largest South & Central America brain health supplements market share in 2022.
Based on dosage form, the South & Central America brain health supplements market is segmented into capsules, tablets, and others. The others segment held the largest South & Central America brain health supplements market share in 2022.
Based on distribution channel, the South & Central America brain health supplements market is segmented into supermarket and hypermarket, drug store, online and others. The supermarket and hypermarket segment held the largest South & Central America brain health supplements market share in 2022.
Based on age category, the South & Central America brain health supplements market is segmented into adults, children, and elderly. The adults segment held the largest South & Central America brain health supplements market share in 2022.
Based on country, the South & Central America brain health supplements market has been categorized into Brazil, Argentina, and the Rest of South & Central America. Brazil dominated the South & Central America brain health supplements market in 2022.
Apsen Farmaceutica SA, Evonik Industries AG, Plants Med Laboratories Pvt Ltd, Labonathus Biotecnologia Internacional Ltda., and Zeon Biotech Pvt Ltd, are some of the leading companies operating in the brain health supplements market in the region.
Emerging Markets in Developing Countries Fuels South & Central America Brain Health Supplements Market
Leading companies in the brain health supplements market are focused on increasing their penetration across emerging markets by expanding their distribution networks and augmenting their manufacturing capabilities. Emerging markets in Brazil are expected to offer potential growth opportunities to key brain health supplement manufacturers in the future. This can be attributed to the availability of a large patient pool with the growing elderly population; high prevalence of depression, anxiety, mood swings, and other mental and cognitive disorders; increasing levels of disposable income; and improving infrastructure in the healthcare sector.Further, high investments by governments in these countries in life science and health research favor the upgrading of facilities with the latest technologies. This is also driving the brain health supplements market players toward developing regions.
South & Central America Brain Health Supplements Market Overview
The South & Central America brain health supplements market is segmented into Brazil, Argentina, and the Rest of South & Central America. The regional market is primarily dominated by Brazil. The market's growth is attributed to the rising demand for brain health supplements, increasing investments in manufacturing and R&D activities, and new product launches. In March 2020, the Wiley company announced the formulation of its first omega-3 concentrate in powder form, its drug release, and consumer dietary supplements in South & Central America. The MSC-certified omega-3 concentrate powder has been designed for use in dietary supplements and food & beverages.South & Central America Brain Health Supplements Market Revenue and Forecast to 2028 (US$ Million)
South & Central America Brain Health Supplements Market Segmentation
The South & Central America brain health supplements market is segmented into product, application, dosage form, distribution channel, age category, and country.Based on product, the South & Central America brain health supplements market is segmented into natural molecules, herbal extract, and vitamins and minerals. The natural molecules segment registered the largest South & Central America brain health supplements market share in 2022. The natural molecules is further subsegmented into acetyl-L-carnitine, docosahexaenoic Acid (DHA), alpha GPC, citicoline, huperzine-A, and others. The herbal extract is further subsegmented into bacopa monnieri, ginkgo biloba, ginseng, curcumin, lion's mane, and others. The vitamins and minerals is further subsegmented into vitamins C and E, vitamin B complex and others.
Based on application, the South & Central America brain health supplements market is segmented into memory enhancement, attention and focus, depression and mood, sleep and recovery, anti-aging and longevity, and others. The memory enhancement segment held the largest South & Central America brain health supplements market share in 2022.
Based on dosage form, the South & Central America brain health supplements market is segmented into capsules, tablets, and others. The others segment held the largest South & Central America brain health supplements market share in 2022.
Based on distribution channel, the South & Central America brain health supplements market is segmented into supermarket and hypermarket, drug store, online and others. The supermarket and hypermarket segment held the largest South & Central America brain health supplements market share in 2022.
Based on age category, the South & Central America brain health supplements market is segmented into adults, children, and elderly. The adults segment held the largest South & Central America brain health supplements market share in 2022.
Based on country, the South & Central America brain health supplements market has been categorized into Brazil, Argentina, and the Rest of South & Central America. Brazil dominated the South & Central America brain health supplements market in 2022.
Apsen Farmaceutica SA, Evonik Industries AG, Plants Med Laboratories Pvt Ltd, Labonathus Biotecnologia Internacional Ltda., and Zeon Biotech Pvt Ltd, are some of the leading companies operating in the brain health supplements market in the region.
Table of Contents
1. Introduction
3. Research Methodology
4. South & Central America Brain Health Supplements Market - Market Landscape
5. South & Central America Brain Health Supplements Market - Key Market Dynamics
6. Brain Health Supplements Market - South & Central America Analysis
7. South & Central America Brain Health Supplements Market - Revenue and Forecast to 2028 - by Product
8. South & Central America Brain Health Supplements Market - Revenue and Forecast to 2028 - by Application
9. South & Central America Brain Health Supplements Market - Revenue and Forecast to 2028 - by Dosage Form
10. South & Central America Brain Health Supplements Market - Revenue and Forecast to 2028 - by Distribution Channel
11. South & Central America Brain Health Supplements Market - Revenue and Forecast to 2028 - by Age Category
12. South & Central America Brain Health Supplements Market - Revenue and Forecast to 2028 - Country Analysis
13. Company Profiles
14. South & Central America Brain Health Supplements Market - Industry Landscape
15. Appendix
List of Tables
List of Figures
Executive Summary
At 10.7% CAGR, the South & Central America Brain Health Supplements Market is Speculated to be Worth US$ 1,206.94 million by 2028.According to this research,, the South & Central America brain health supplements market was valued at US$ 655.64 million in 2022 and is expected to reach US$ 1,206.94 million by 2028, registering a CAGR of 10.7% from 2022 to 2028. Growing prevalence of major depressive disorders and increasing demand for brain supplements among elderly population are the critical factors attributed to the South & Central America brain health supplements market expansion.
Brain health supplements contain natural molecules, herbal extracts, vitamins, and minerals. These products assist in the enhancement of memory, attention, and focus; management of depression and mood; and improvement of sleep and recovery pace. Some of these products also exhibit anti-aging properties and stimulate longevity. Therefore, companies in the brain health supplements market are launching various products to enhance the treatment outputs. A few of the recent developments related to the brain health supplements market are mentioned below:
• In November 2021, Danone launched Souvenaid in powder form. Souvenaid is a medical nutrition drink to support memory function in the early stages of Alzheimer’s disease.
• In January 2022, HVMN Inc. launched HVMN Ketone 2.0 (Ketone-IQ). The company had plans to begin its pre-sales in November 2021, followed by a public launch in January 2022. The product delivers energy to power the brain and body.
• In June 2021, Motiva Supplements launched Neuro Booster, which proposes the higher absorption of six key functional foods. It is the first-ever clinically proven product to help enhance Alzheimer’s patients and improve brain health.
Thus, the active participation of market players through innovations and product developments is likely to bring new trends to the brain health supplements market in the coming years.
On the contrary, lack of regulations and false claims by manufacturers hurdles the growth of South & Central America brain health supplements market.
Based on product, the South & Central America brain health supplements market is segmented into natural molecules, herbal extract, and vitamins and minerals. The natural molecules segment held 46.7% share of South & Central America brain health supplements market in 2022, amassing US$ 306.28 million. It is projected to garner US$ 553.81 million by 2028 to expand at 10.4% CAGR during 2022-2028. The natural molecules segment is further subsegmented into acetyl-L-carnitine, docosahexaenoic Acid (DHA), alpha GPC, citicoline, huperzine-A, and others. The herbal extract is further subsegmented into bacopa monnieri, ginkgo biloba, ginseng, curcumin, lion's mane, and others. The vitamins and minerals segment is further subsegmented into vitamins C and E, vitamin B complex and others.
Based on application, the South & Central America brain health supplements market is segmented into memory enhancement, attention and focus, depression and mood, sleep and recovery, anti-aging and longevity, and others. The memory enhancement segment held 31.1% share of South & Central America brain health supplements market in 2022, amassing US$ 203.65 million. It is projected to garner US$ 381.41 million by 2028 to expand at 11.0% CAGR during 2022-2028.
Based on dosage form, the South & Central America brain health supplements market is segmented into capsules, tablets, and others. The others segment held 44.7% share of South & Central America brain health supplements market in 2022, amassing US$ 293.07 million. It is projected to garner US$ 554.83 million by 2028 to expand at 11.2% CAGR during 2022-2028.
Based on distribution channel, the South & Central America brain health supplements market is segmented into supermarket and hypermarket, drug store, online and others. The supermarket and hypermarket segment held 39.5% share of South & Central America brain health supplements market in 2022, amassing US$ 259.14 million. It is projected to garner US$ 483.07 million by 2028 to expand at 10.9% CAGR during 2022-2028.
Based on age category, the South & Central America brain health supplements market is segmented into adults, children, and elderly. The adults segment held 47.7% share of South & Central America brain health supplements market in 2022, amassing US$ 312.83 million. It is projected to garner US$ 592.53 million by 2028 to expand at 11.2% CAGR during 2022-2028.
Based on country, the South & Central America brain health supplements market has been categorized into Brazil, Argentina, and the Rest of South & Central America. Our regional analysis states that Brazil captured 61.4% share of South & Central America brain health supplements market in 2022. It was assessed at US$ 402.58 million in 2022 and is likely to hit US$ 744.88 million by 2028, exhibiting a CAGR of 10.8% during 2022-2028.
Key players operating in the South & Central America brain health supplements market are Apsen Farmaceutica SA, Evonik Industries AG, Plants Med Laboratories Pvt Ltd, Labonathus Biotecnologia Internacional Ltda., and Zeon Biotech Pvt Ltd, among others.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Apsen Farmaceutica SA
- Evonik Industries AG
- Plants Med Laboratories Pvt Ltd
- Zeon Biotech Pvt Ltd
- Labonathus Biotecnologia Internacional Ltda.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 144 |
| Published | December 2023 |
| Forecast Period | 2022 - 2028 |
| Estimated Market Value in 2022 | 655.64 Million |
| Forecasted Market Value by 2028 | 1206.94 Million |
| Compound Annual Growth Rate | 10.7% |
